Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 20, 2006. The report serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific transaction event rather than general financial performance.
Material Changes
A re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan") resulted in an increase in the notional allocation of Ordinary Share ADRs on February 16, 2006. The transaction price was $51.32 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. It strictly reports a compliance notification under Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Important Facts for Investors
- Transaction Date: February 16, 2006 (Notification date: February 20, 2006).
- Share Price: $51.32 per Ordinary Share ADR.
- Event: Increase in notional allocation of shares for plan participants.
- Participants: Dr J P Garnier (58 shares), Dr W Calhoun (10 shares), Dr R Greig (71 shares), Mr D Phelan (176 shares), Dr D Pulman (12 shares), Mr D Stout (27 shares), Mr C Viehbacher (3 shares), and Dr T Yamada (20 shares).